{'fraction_non_alphanumeric': 0.011363636363636364, 'fraction_numerical': 0.0, 'mean_word_length': 6.091954022988506, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Procalcitonin predicts mortality in HIV‐infected Ugandan adults with lower respiratory tract infections

In low and middle‐income countries where HIV infection is prevalent, identifying patients at high risk of dying from lower respiratory tract infections is challenging and validated prognostic models are lacking. Serum procalcitonin may be a useful prognostic tool in these settings. We sought to determine if elevated serum procalcitonin is associated with increased in‐hospital mortality and to combine serum procalcitonin with available clinical characteristics to create a clinically useful prognostic model.